111 related articles for article (PubMed ID: 15112185)
1. Three diabetic peritoneal dialysis patients receiving intraperitoneal insulin with dosage adjustment based on capillary glucose levels during peritoneal equilibrium tests.
Thorp ML; Wilks TS
Am J Kidney Dis; 2004 May; 43(5):927-9. PubMed ID: 15112185
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal insulin: new alternative for diabetic CAPD patients.
Bandel-Walcer R; Myers C; Malgaonkar S; Lyman N
AANNT J; 1982 Aug; 9(4):31-5. PubMed ID: 7049191
[No Abstract] [Full Text] [Related]
3. Estimate the insulin absorption in diabetic patients on peritoneal dialysis.
Pantsulaia T; Chokhonelidze I; Lomitashvili T
Georgian Med News; 2006 Nov; (140):28-30. PubMed ID: 17179582
[TBL] [Abstract][Full Text] [Related]
4. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of transperitoneal insulin transport.
Widerøe TE; Dahl KJ; Smeby LC; Balstad T; Cruischank-Flakne S; Følling I; Simondsen O; Ahlmen J; Jørstad S
Nephron; 1996; 74(2):283-90. PubMed ID: 8893142
[TBL] [Abstract][Full Text] [Related]
6. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
Quellhorst E
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
[TBL] [Abstract][Full Text] [Related]
7. The impact of intraperitoneal glucose and insulin on the liver.
Bargman JM
Perit Dial Int; 1996; 16 Suppl 1():S211-4. PubMed ID: 8728195
[No Abstract] [Full Text] [Related]
8. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
[No Abstract] [Full Text] [Related]
9. Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats.
Mactier RA; Moore H; Khanna R; Shah J
Nephron; 1990; 54(3):240-4. PubMed ID: 2179758
[TBL] [Abstract][Full Text] [Related]
10. [Intraperitoneal insulin in continuous ambulatory peritoneal dialysis].
Riambau E; Aubia J; Llorach I; Lloveras J; Masramón J; Orfila A; Llorach M
Rev Clin Esp; 1982 Mar; 164(5):333-4. PubMed ID: 7048442
[No Abstract] [Full Text] [Related]
11. Subcutaneous and intraperitoneal insulin therapy in diabetic patients on CAPD.
Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
Perit Dial Int; 1996; 16 Suppl 1():S288-91. PubMed ID: 8728209
[TBL] [Abstract][Full Text] [Related]
12. [Peritoneal dialysis for diabetic nephropathy: a case of intraperitoneal insulin administration].
Abe T; Kusumi H; Kanazawa M
Hinyokika Kiyo; 1972 Mar; 18(3):133-6. PubMed ID: 5065298
[No Abstract] [Full Text] [Related]
13. [Continuous ambulatory peritoneal dialysis treatment and blood glucose control in diabetics with end-stage diabetic nephropathy].
Li GW; Liu J; Chen L
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):360-3, 382. PubMed ID: 2684575
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
[No Abstract] [Full Text] [Related]
15. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal insulin in diabetic CAPD patients.
Mactier RA; Khanna R
Int J Artif Organs; 1988 Jan; 11(1):9-12. PubMed ID: 3283057
[No Abstract] [Full Text] [Related]
17. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
[No Abstract] [Full Text] [Related]
18. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
Chen HC; Lai YH; Tsai CY; Shin SJ; Tsai JH
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
[TBL] [Abstract][Full Text] [Related]
19. Decreasing insulin requirements in CAPD patients given intraperitoneal insulin.
Grefberg N; Danielson BG; Berne C
J Diabet Complications; 1987; 1(1):16-9. PubMed ID: 2968990
[TBL] [Abstract][Full Text] [Related]
20. Insulin prescription, glycemic control, and diabetic complications in diabetics treated by continuous ambulatory peritoneal dialysis.
Rottembourg J; Issad B; Allouache M
Perit Dial Int; 1993; 13 Suppl 2():S232-5. PubMed ID: 8399575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
